Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1982 1
1985 1
2000 1
2001 1
2007 1
2008 1
2009 3
2010 1
2011 1
2012 1
2013 1
2014 2
2015 4
2016 5
2017 3
2018 1
2019 5
2020 10
2021 6
2022 4
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.
Laboratory assessment of vitamin K status.
Card DJ, Gorska R, Harrington DJ. Card DJ, et al. J Clin Pathol. 2020 Feb;73(2):70-75. doi: 10.1136/jclinpath-2019-205997. Epub 2019 Dec 20. J Clin Pathol. 2020. PMID: 31862867 Review.
Vitamin K is required for the -carboxylation of specific glutamic acid residues within the Gla domain of the 17 vitamin K-dependent proteins (VKDPs). ...The measurement of phylloquinone (K(1)) in serum is the most commonly used marker of vitamin K stat …
Vitamin K is required for the -carboxylation of specific glutamic acid residues within the Gla domain of the 17 vitamin K-depe …
Vitamin K metabolism: current knowledge and future research.
Card DJ, Gorska R, Cutler J, Harrington DJ. Card DJ, et al. Mol Nutr Food Res. 2014 Aug;58(8):1590-600. doi: 10.1002/mnfr.201300683. Epub 2013 Dec 27. Mol Nutr Food Res. 2014. PMID: 24376012 Review.
Research into vitamin K metabolism is essential for the understanding of vitamin K biology in health and disease. ...Areas of interest discussed in this review include prophylactic administration of vitamin K1 in term and preterm neonates, interactions between vitam …
Research into vitamin K metabolism is essential for the understanding of vitamin K biology in health and disease. ...Areas of …
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Green JB, Bethel MA, Armstrong PW, Buse JB, Engel SS, Garg J, Josse R, Kaufman KD, Koglin J, Korn S, Lachin JM, McGuire DK, Pencina MJ, Standl E, Stein PP, Suryawanshi S, Van de Werf F, Peterson ED, Holman RR; TECOS Study Group. Green JB, et al. N Engl J Med. 2015 Jul 16;373(3):232-42. doi: 10.1056/NEJMoa1501352. Epub 2015 Jun 8. N Engl J Med. 2015. PMID: 26052984 Free article. Clinical Trial.
The additive effect of vitamin K supplementation and bisphosphonate on fracture risk in post-menopausal osteoporosis: a randomised placebo controlled trial.
Moore AE, Dulnoan D, Voong K, Ayis S, Mangelis A, Gorska R, Harrington DJ, Tang JCY, Fraser WD, Hampson G. Moore AE, et al. Arch Osteoporos. 2023 Jun 20;18(1):83. doi: 10.1007/s11657-023-01288-w. Arch Osteoporos. 2023. PMID: 37338608 Free PMC article. Clinical Trial.
PURPOSE: Some clinical studies have suggested that vitamin K prevents bone loss and may improve fracture risk. The aim was to assess whether vitamin K supplementation has an additive effect on bone mineral density (BMD), hip geometry and bone turnover markers (BTMs) …
PURPOSE: Some clinical studies have suggested that vitamin K prevents bone loss and may improve fracture risk. The aim was to assess …
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.
Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV, Lawson FC, Ping L, Wei X, Lewis EF, Maggioni AP, McMurray JJ, Probstfield JL, Riddle MC, Solomon SD, Tardif JC; ELIXA Investigators. Pfeffer MA, et al. N Engl J Med. 2015 Dec 3;373(23):2247-57. doi: 10.1056/NEJMoa1509225. N Engl J Med. 2015. PMID: 26630143 Free article. Clinical Trial.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Serum vitamin K(1) (phylloquinone) is associated with fracture risk and hip strength in post-menopausal osteoporosis: A cross-sectional study.
Moore AE, Kim E, Dulnoan D, Dolan AL, Voong K, Ahmad I, Gorska R, Harrington DJ, Hampson G. Moore AE, et al. Bone. 2020 Dec;141:115630. doi: 10.1016/j.bone.2020.115630. Epub 2020 Sep 10. Bone. 2020. PMID: 32919111
PURPOSE: Vitamin K may play a potential role in bone metabolism, although further evidence is needed. ...Higher concentrations of serum vitamin K(1) may be required for vitamin K's skeletal effects compared to coagulation. ...
PURPOSE: Vitamin K may play a potential role in bone metabolism, although further evidence is needed. ...Higher concentrations of ser …
Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis.
Piotrowski WJ, Martusewicz-Boros MM, Białas AJ, Barczyk A, Batko B, Błasińska K, Boros PW, Górska K, Grzanka P, Jassem E, Jastrzębski D, Kaczyńska J, Kowal-Bielecka O, Kucharz E, Kuś J, Kuźnar-Kamińska B, Kwiatkowska B, Langfort R, Lewandowska K, Mackiewicz B, Majewski S, Makowska J, Miłkowska-Dymanowska J, Puścińska E, Siemińska A, Sobiecka M, Soroka-Dąda RA, Szołkowska M, Wiatr E, Ziora D, Śliwiński P. Piotrowski WJ, et al. Adv Respir Med. 2022 Oct 4;90(5):425-450. doi: 10.3390/arm90050052. Adv Respir Med. 2022. PMID: 36285980 Free PMC article. Review.
58 results